BRPI0919931A2 - complexos de metal de transição de um composto de bis[tiohidrazida] - Google Patents
complexos de metal de transição de um composto de bis[tiohidrazida]Info
- Publication number
- BRPI0919931A2 BRPI0919931A2 BRPI0919931A BRPI0919931A BRPI0919931A2 BR PI0919931 A2 BRPI0919931 A2 BR PI0919931A2 BR PI0919931 A BRPI0919931 A BR PI0919931A BR PI0919931 A BRPI0919931 A BR PI0919931A BR PI0919931 A2 BRPI0919931 A2 BR PI0919931A2
- Authority
- BR
- Brazil
- Prior art keywords
- thiohydrazide
- bis
- compound
- transition metal
- metal complexes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 229910052723 transition metal Inorganic materials 0.000 title 1
- 150000003624 transition metals Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/04—Nickel compounds
- C07F15/045—Nickel compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/38—Amides of thiocarboxylic acids
- C07C327/56—Amides of thiocarboxylic acids having nitrogen atoms of thiocarboxamide groups further bound to another hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/08—Copper compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/01—Charge-transfer complexes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19694308P | 2008-10-22 | 2008-10-22 | |
| PCT/US2009/061491 WO2010048293A1 (en) | 2008-10-22 | 2009-10-21 | Transition metal complexes of a bis[thiohydrazide amide] compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0919931A2 true BRPI0919931A2 (pt) | 2019-09-24 |
Family
ID=42119655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0919931A BRPI0919931A2 (pt) | 2008-10-22 | 2009-10-21 | complexos de metal de transição de um composto de bis[tiohidrazida] |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8461199B2 (pt) |
| EP (1) | EP2373624A4 (pt) |
| JP (1) | JP2012506444A (pt) |
| KR (1) | KR20110081300A (pt) |
| CN (1) | CN102256949B (pt) |
| AU (1) | AU2009308511B2 (pt) |
| BR (1) | BRPI0919931A2 (pt) |
| CA (1) | CA2740925A1 (pt) |
| IL (1) | IL212438A0 (pt) |
| MX (1) | MX2011004114A (pt) |
| WO (1) | WO2010048293A1 (pt) |
| ZA (1) | ZA201103010B (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009507770A (ja) * | 2005-07-27 | 2009-02-26 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド | 眼性疾患の治療への、熱ショックの使用 |
| MX2009001877A (es) | 2006-08-21 | 2009-03-02 | Synta Pharmaceuticals Corp | Compuestos para el tratamiento de trastornos proliferativos. |
| US8618170B2 (en) | 2007-11-09 | 2013-12-31 | Synta Pharmaceuticals Corp. | Oral formulations of bis(thiohydrazide amides) |
| WO2009105257A1 (en) | 2008-02-21 | 2009-08-27 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
| WO2009123704A2 (en) * | 2008-03-31 | 2009-10-08 | Synta Pharmaceuticals Corp. | Process for preparing bis(thiohydrazide amides) |
| BRPI0919720A2 (pt) | 2008-10-22 | 2015-12-08 | Synta Pharmaceuticals Corp | complexos de metal de transição de compostos bis-[tio hidrazida amida |
| CN102256949B (zh) * | 2008-10-22 | 2014-09-24 | 辛塔医药品有限公司 | 双[硫代酰肼酰胺]化合物的过渡金属络合物 |
| US8680100B2 (en) | 2008-12-01 | 2014-03-25 | Synta Pharmaceuticals Corp. | Sulfonylhydrazide compounds for treating proliferative disorders |
| US8822532B2 (en) | 2009-12-04 | 2014-09-02 | Synta Pharmaceuticals Corp. | Bis[thiohydrazide amide] compounds for treating leukemia |
| US8815945B2 (en) | 2010-04-20 | 2014-08-26 | Masazumi Nagai | Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers |
| AU2012335105A1 (en) | 2011-11-10 | 2014-06-19 | Synta Pharmaceuticals Corp. | Administration of a bis(thiohydrazide amide) compound for treating cancers |
| WO2013103795A1 (en) | 2012-01-05 | 2013-07-11 | The Board Of Trustees Of The Leland Stanford Junior University | Bis (thiohydrazide amide) compounds for treating cancers |
| KR102187680B1 (ko) * | 2014-02-13 | 2020-12-07 | 엘지이노텍 주식회사 | 터치 윈도우 |
| US9950194B2 (en) | 2014-09-09 | 2018-04-24 | Mevion Medical Systems, Inc. | Patient positioning system |
| CN105739155B (zh) * | 2016-04-29 | 2019-03-12 | 京东方科技集团股份有限公司 | 触控基板和触控液晶显示面板 |
| CN112930178A (zh) * | 2018-07-12 | 2021-06-08 | 得克萨斯农业及机械体系综合大学 | 用于治疗铜缺乏的组合物和使用方法 |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS583499B2 (ja) | 1975-07-28 | 1983-01-21 | 旭化成株式会社 | アンテイカサレタ ポリウレタンソセイブツ |
| TWI252847B (en) | 2001-07-10 | 2006-04-11 | Synta Pharmaceuticals Corp | Synthesis of taxol enhancers |
| US6924312B2 (en) | 2001-07-10 | 2005-08-02 | Synta Pharmaceuticals Corp. | Taxol enhancer compounds |
| TWI297335B (en) | 2001-07-10 | 2008-06-01 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| TWI332943B (en) | 2001-07-10 | 2010-11-11 | Synta Pharmaceuticals Corp | Taxol enhancer compounds |
| TWI330079B (en) | 2003-01-15 | 2010-09-11 | Synta Pharmaceuticals Corp | Treatment for cancers |
| EP2305642A3 (en) | 2004-06-23 | 2011-12-14 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amide) salts for treatment of cancers |
| US20060142393A1 (en) | 2004-09-16 | 2006-06-29 | Sherman Matthew L | Bis(thio-hydrazide amides) for treatment of hyperplasia |
| US20060167106A1 (en) | 2004-11-19 | 2006-07-27 | Mei Zhang | Compounds acting at the centrosome |
| AU2005306471B2 (en) | 2004-11-19 | 2009-12-17 | Synta Pharmaceuticals Corp. | Bis(thio-hydrazide amides) for increasing Hsp70 expression |
| CA2603314A1 (en) | 2005-04-15 | 2006-10-26 | Synta Pharmaceuticals Corp. | Methods of increasing natural killer cell activity for therapy |
| BRPI0610219A2 (pt) | 2005-04-15 | 2010-06-08 | Synta Pharmaceuticals Corp | métodos de tratamento de um ser humano com cáncer e composição de farmacêutica |
| WO2006124736A2 (en) | 2005-05-16 | 2006-11-23 | Synta Pharmaceuticals Corp. | Synthesis of bis(thio-hydrazide amide) salts |
| NZ565996A (en) | 2005-08-16 | 2011-04-29 | Synta Pharmaceuticals Corp | Bis(thio-hydrazide amide) formulation |
| WO2008024302A2 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
| MX2009001877A (es) | 2006-08-21 | 2009-03-02 | Synta Pharmaceuticals Corp | Compuestos para el tratamiento de trastornos proliferativos. |
| EP2057118B1 (en) | 2006-08-21 | 2015-03-04 | Synta Pharmaceuticals Corp. | Compounds for treatment of proliferative disorders |
| WO2008024299A2 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Combination with bis(thiohydrazide amides) for treating cancer |
| AU2007288340A1 (en) | 2006-08-21 | 2008-02-28 | Synta Pharmaceuticals Corp. | Bis (thiohydrazide amides) for treating melanoma |
| US20080176828A1 (en) | 2006-08-21 | 2008-07-24 | Martin Williams | Treating melanoma with BIS(THIOHYDRAZIDE AMIDES) |
| WO2008027445A2 (en) | 2006-08-31 | 2008-03-06 | Synta Pharmaceuticals Corp. | Combination with bis(thiohydrazide amides) for treating cancer |
| AU2007294969A1 (en) | 2006-09-11 | 2008-03-20 | Synta Pharmaceuticals Corp. | Bis (thiohydrazide amides) formulation |
| WO2008033494A2 (en) | 2006-09-15 | 2008-03-20 | Synta Pharmaceuticals Corp. | Purification of bis(thiohydrazide amides) |
| WO2008082579A1 (en) | 2007-01-03 | 2008-07-10 | Synta Pharmaceuticals Corp. | Method for treating cancer |
| US8093425B2 (en) | 2007-04-30 | 2012-01-10 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
| TW200922550A (en) | 2007-08-07 | 2009-06-01 | Synta Pharmaceuticals Corp | Compounds for treating proliferative disorders |
| EP2225201A2 (en) | 2007-11-28 | 2010-09-08 | Synta Pharmaceuticals Corp. | Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide) |
| WO2009105257A1 (en) | 2008-02-21 | 2009-08-27 | Synta Pharmaceuticals Corp. | Compounds for treating proliferative disorders |
| WO2009123704A2 (en) | 2008-03-31 | 2009-10-08 | Synta Pharmaceuticals Corp. | Process for preparing bis(thiohydrazide amides) |
| CN102256949B (zh) | 2008-10-22 | 2014-09-24 | 辛塔医药品有限公司 | 双[硫代酰肼酰胺]化合物的过渡金属络合物 |
| BRPI0919720A2 (pt) | 2008-10-22 | 2015-12-08 | Synta Pharmaceuticals Corp | complexos de metal de transição de compostos bis-[tio hidrazida amida |
| US8680100B2 (en) | 2008-12-01 | 2014-03-25 | Synta Pharmaceuticals Corp. | Sulfonylhydrazide compounds for treating proliferative disorders |
| US8822532B2 (en) * | 2009-12-04 | 2014-09-02 | Synta Pharmaceuticals Corp. | Bis[thiohydrazide amide] compounds for treating leukemia |
| US8815945B2 (en) * | 2010-04-20 | 2014-08-26 | Masazumi Nagai | Use of bis [thiohydrazide amide] compounds such as elesclomol for treating cancers |
-
2009
- 2009-10-21 CN CN200980151296.4A patent/CN102256949B/zh not_active Expired - Fee Related
- 2009-10-21 AU AU2009308511A patent/AU2009308511B2/en not_active Ceased
- 2009-10-21 BR BRPI0919931A patent/BRPI0919931A2/pt not_active IP Right Cessation
- 2009-10-21 US US13/125,016 patent/US8461199B2/en not_active Expired - Fee Related
- 2009-10-21 KR KR1020117011625A patent/KR20110081300A/ko not_active Application Discontinuation
- 2009-10-21 JP JP2011533298A patent/JP2012506444A/ja active Pending
- 2009-10-21 CA CA2740925A patent/CA2740925A1/en not_active Abandoned
- 2009-10-21 MX MX2011004114A patent/MX2011004114A/es active IP Right Grant
- 2009-10-21 WO PCT/US2009/061491 patent/WO2010048293A1/en active Application Filing
- 2009-10-21 EP EP20090822631 patent/EP2373624A4/en not_active Withdrawn
-
2011
- 2011-04-17 IL IL212438A patent/IL212438A0/en unknown
- 2011-04-20 ZA ZA2011/03010A patent/ZA201103010B/en unknown
-
2013
- 2013-05-24 US US13/902,270 patent/US8802725B2/en not_active Expired - Fee Related
-
2014
- 2014-08-08 US US14/455,458 patent/US20150031758A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20150031758A1 (en) | 2015-01-29 |
| US8802725B2 (en) | 2014-08-12 |
| US20110288162A1 (en) | 2011-11-24 |
| WO2010048293A1 (en) | 2010-04-29 |
| EP2373624A4 (en) | 2014-06-11 |
| CN102256949B (zh) | 2014-09-24 |
| EP2373624A1 (en) | 2011-10-12 |
| AU2009308511B2 (en) | 2013-03-07 |
| CN102256949A (zh) | 2011-11-23 |
| CA2740925A1 (en) | 2010-04-29 |
| JP2012506444A (ja) | 2012-03-15 |
| US20140011864A1 (en) | 2014-01-09 |
| KR20110081300A (ko) | 2011-07-13 |
| US8461199B2 (en) | 2013-06-11 |
| IL212438A0 (en) | 2011-06-30 |
| AU2009308511A1 (en) | 2010-04-29 |
| ZA201103010B (en) | 2012-01-25 |
| MX2011004114A (es) | 2011-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0919931A2 (pt) | complexos de metal de transição de um composto de bis[tiohidrazida] | |
| ZA201103015B (en) | Transition metal complexes of bis[thiohydrazide]compounds | |
| CY2017026I2 (el) | Τετρακυκλικη ενωση | |
| DE112010004049A5 (de) | Metallkomplexe | |
| DE112010003663A5 (de) | Metallkomplexe | |
| DE112010000747A5 (de) | Metallkomplexe | |
| BRPI0914254A2 (pt) | compostos anti-infectivos | |
| DE112011102366A5 (de) | Metallkomplexe | |
| DE112011102008A5 (de) | Metallkomplexe | |
| DE112011102372A5 (de) | Metallkomplexe | |
| DK2291384T3 (da) | Metalorganiske skeletforbindelser | |
| DE112011102367A5 (de) | Metallkomplexe | |
| BRPI0822877A2 (pt) | Montagem de cilindro de fechadura rechavetável | |
| BRPI0906098B8 (pt) | método de preparação de um composto | |
| GB0808840D0 (en) | A compound structure | |
| BRPI1013868A2 (pt) | composto diaciletilenodiamina | |
| BRPI0924653A2 (pt) | composto de ferro-oligossacarídeo estável | |
| DK2305275T3 (da) | Væskesammensætning omfattende cisplatinkoordinerende forbindelse | |
| BRPI1007017A2 (pt) | uso de um composto. | |
| DE112011104390A5 (de) | Metallkomplexe | |
| BRPI0923592A2 (pt) | composto | |
| BRPI0911393A2 (pt) | composto de 5-hidroxipirimidina-4-carboxamida | |
| DE112011103177A5 (de) | Phosphorhaltige Metallkomplexe | |
| BRPI0909461A2 (pt) | Composto de enaminotiocarbonila substituídos | |
| BRPI0923114A2 (pt) | Compostos de fenazopiridina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |